Definity (Lantheus Medical Imaging, Inc.)


Welcome to the PulseAid listing for the Definity drug offered from Lantheus Medical Imaging, Inc.. This Contrast Agent for Ultrasound Imaging [EPC],Ultrasound Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Lantheus Medical Imaging, Inc.
NON-PROPRIETARY NAME: perflutren
SUBSTANCE NAME: PERFLUTREN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Contrast Agent for Ultrasound Imaging [EPC],Ultrasound Contrast Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2001-07-31
END MARKETING DATE: 0000-00-00


Definity HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDefinity from Lantheus Medical Imaging, Inc.
LABELER NAME: Lantheus Medical Imaging, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6.52(mg/mL)
START MARKETING DATE: 2001-07-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 11994-011_c93d3f05-f26b-4ca7-bfac-0f6b95b96418
PRODUCT NDC: 11994-011
APPLICATION NUMBER: NDA021064

Other PERFLUTREN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Lantheus Medical Imaging, Inc.Definity